Stoke Therapeutics Inc (STOK) Insider Trading
- $55,396,431.33
- $100,063,175.23
- March 19, 2026
- Barry Ticho
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 19, 2026 | Insider | 1,461 | $29.99 | Sell | $43,815.39 | |
| March 18, 2026 | Insider | 6,686 | $31.34 | Sell | $209,539.24 | |
| March 18, 2026 | General Counsel | 4,628 | $31.34 | Sell | $145,041.52 | |
| March 18, 2026 | CFO | 2,382 | $31.34 | Sell | $74,651.88 | |
| March 18, 2026 | Insider | 1,931 | $31.34 | Sell | $60,517.54 | |
| March 17, 2026 | Insider | 6,164 | $33.01 | Sell | $203,473.64 | |
| March 17, 2026 | CFO | 2,196 | $33.01 | Sell | $72,489.96 | |
| March 17, 2026 | General Counsel | 4,267 | $33.01 | Sell | $140,853.67 | |
| March 17, 2026 | Insider | 1,781 | $33.01 | Sell | $58,790.81 | |
| March 13, 2026 | Director | 605 | $36.80 | Sell | $22,264.00 | |
| March 10, 2026 | Insider | 4,355 | $40.00 | Sell | $174,200.00 | |
| March 10, 2026 | Director | 33,243 | $39.74 | Sell | $1,321,076.82 | |
| Sept. 3, 2025 | Director | 45,996 | $20.13 | Sell | $925,899.48 | |
| Sept. 3, 2025 | General Counsel | 6,345 | $20.07 | Sell | $127,344.15 | |
| Sept. 2, 2025 | Director | 14,860 | $20.14 | Sell | $299,280.40 | |
| Sept. 2, 2025 | Insider | 5,501 | $19.87 | Sell | $109,304.87 | |
| Sept. 2, 2025 | General Counsel | 14,922 | $20.14 | Sell | $300,529.08 | |
| Aug. 29, 2025 | Director | 1,029 | $20.00 | Sell | $20,580.00 | |
| Aug. 29, 2025 | General Counsel | 850 | $20.00 | Sell | $17,000.00 | |
| Aug. 13, 2025 | General Counsel | 13,712 | $15.00 | Sell | $205,680.00 | |
| Aug. 1, 2025 | Insider | 4,504 | $12.82 | Sell | $57,741.28 | |
| June 3, 2025 | Insider | 6,471 | $10.03 | Sell | $64,904.13 | |
| June 2, 2025 | Insider | 1,745 | $10.00 | Sell | $17,450.00 | |
| March 18, 2025 | Insider | 3,884 | $8.67 | Sell | $33,674.28 | |
| March 18, 2025 | Director | 10,382 | $8.67 | Sell | $90,011.94 | |
| March 18, 2025 | General Counsel | 2,266 | $8.67 | Sell | $19,646.22 | |
| Dec. 9, 2024 | General Counsel | 13,666 | $13.61 | Sell | $185,994.26 | |
| Dec. 9, 2024 | CEO | 6,786 | $12.99 | Sell | $88,150.14 | |
| Dec. 9, 2024 | Insider | 2,586 | $12.99 | Sell | $33,592.14 | |
| Dec. 6, 2024 | CEO | 6,170 | $12.78 | Sell | $78,852.60 | |
| Dec. 6, 2024 | Insider | 13,945 | $12.78 | Sell | $178,217.10 | |
| Dec. 6, 2024 | General Counsel | 9,696 | $12.78 | Sell | $123,914.88 | |
| Dec. 2, 2024 | Insider | 10,000 | $12.07 | Sell | $120,700.00 | |
| Sept. 19, 2024 | Major Shareholder | 1,937,500 | $14.05 | Sell | $27,221,875.00 | |
| July 1, 2024 | Insider | 10,000 | $13.75 | Sell | $137,500.00 | |
| April 17, 2024 | Major Shareholder | 3,600,000 | $11.60 | Sell | $41,760,000.00 | |
| March 28, 2024 | General Counsel | 5,126 | $13.20 | Sell | $67,663.20 | |
| March 19, 2024 | CFO | 4,116 | $6.10 | Sell | $25,107.60 | |
| March 19, 2024 | CEO | 11,150 | $6.10 | Sell | $68,015.00 | |
| March 19, 2024 | General Counsel | 2,349 | $6.10 | Sell | $14,328.90 | |
| Feb. 1, 2024 | Insider | 10,000 | $4.80 | Sell | $48,000.00 | |
| Jan. 2, 2024 | Insider | 10,000 | $5.74 | Sell | $57,400.00 | |
| July 3, 2023 | Insider | 15,000 | $10.60 | Sell | $159,000.00 | |
| June 21, 2023 | General Counsel | 1,948 | $13.48 | Sell | $26,259.04 | |
| June 1, 2023 | Insider | 15,000 | $11.13 | Sell | $166,950.00 | |
| May 3, 2023 | Insider | 24,697 | $10.14 | Sell | $250,427.58 | |
| May 1, 2023 | Insider | 24,967 | $10.00 | Sell | $249,670.00 | |
| Feb. 6, 2023 | Insider | 9,235 | $10.02 | Sell | $92,534.70 | |
| Feb. 2, 2023 | Insider | 267 | $10.00 | Sell | $2,670.00 | |
| Jan. 31, 2023 | Insider | 200 | $10.00 | Sell | $2,000.00 |
Insiders are both buying and selling Stoke Therapeutics Inc stock.
The insider traders at Stoke Therapeutics Inc are: Barry Ticho, Huw M Nash, Jonathan Allan, Edward M Md Kaye, Rtw Investments, Lp, Gene Liau, Arthur Tzianabos, Huw M. Nash, Thomas Leggett, Apple Tree Partners Iv, L.P., Jason Hoitt, Skorpios Trust, Stephen J Tulipano, Stephen J. Tulipano, Robin A. Walker, Arthur A Levin, and Adrian R Krainer
The most active insider trader at Stoke Therapeutics Inc is Barry Ticho with 24 trades.
Skorpios Trust has sold the most Stoke Therapeutics Inc stock with a total value of $96,203,750.00.
Apple Tree Partners Iv, L.P. has bought the most Stoke Therapeutics Inc stock with a total value of $54,250,002.00.
The most recent insider trade for Stoke Therapeutics Inc was on March 19, 2026.
The single biggest insider buy for Stoke Therapeutics Inc was from Apple Tree Partners Iv, L.P. with a total value of $25,000,002.00 on June 21, 2019.
The single biggest insider sell for Stoke Therapeutics Inc was from Skorpios Trust with a total value of $41,760,000.00 on April 17, 2024.
